Manulife Expands Hospital Access Across Mainland China, Encompassing Over 38,000 Public and Private Hospitals
For Immediate Release
Hong Kong – Manulife Hong Kong and Macau (“Manulife”) today announced an expansion in the number of hospitals accessible under its individual medical plans across Mainland China, now encompassing over 38,0001 public and private hospitals2. All of Manulife’s medical plans, except the Cancer Treatment Benefit, will now cover eligible medical expenses3 incurred at any public or private hospital2 in Mainland China. Customers covered by any Manulife medical plan4 can access medical services at any public or private hospital2 across the Mainland, according to their individual needs. This enhancement significantly increases the ease and flexibility of seeking cross-border medical treatment, enabling customers to receive timely and appropriate care, while strengthening Manulife’s strong market position in facilitating hospital access across Mainland China.
As demand for cross-border healthcare continues to grow, Manulife is committed to advancing its health protection offerings by providing customers with more comprehensive access to hospitals across Mainland China, thereby reinforcing its customer-centric commitment.
Carrie Tong, Chief Operations Officer of Manulife Hong Kong and Macau, said: “We understand that peace of mind and convenience are paramount for our customers when accessing medical care. By offering access to all public and private hospitals2 across Mainland China, we provide a broad and inclusive healthcare network that truly centres on our customers’ needs. This extensive footprint of hospital access sets us apart, delivering more tailored protection and convenience whenever care is needed. This advancement not only elevates the quality of our service, but also reinforces our role as a trusted partner in health.”
Additionally, Manulife has extended its Credit Service for Hospitalization5,6,7 to over 8008 designated public and private hospitals in Mainland China. This means customers can receive treatment without worrying about upfront payments upon admission, allowing them to focus fully on their recovery. This enhancement further elevates the overall medical experience and underscores Manulife’s commitment to delivering seamless and reassuring health protection.
The content of this press release does not contain the full terms of the policy(ies), and the full terms can be found in the corresponding policy document(s). For product details and key product risks, please refer to the relevant product leaflet. For complete product information of VHIS plans, please visit our website at www.manulife.com.hk.
1 As of the end of 2023. Source: 2023 Statistical Bulletin on the Development of Health and Wellness in China.
2 Refers to any public or private hospital authorized and regulated within the People's Republic of China. Manulife reserves the right to update its List of Designated Hospitals in Mainland China from time to time at its discretion without prior notice. For the definition of “hospital”, please refer to the relevant policy provisions.
3 Claims eligibility and final reimbursement amounts will be assessed in accordance with the terms and conditions specified in the policy provisions, including but not limited to definitions, general exclusions, and benefit limits of product features. For details, please refer to the policy provisions of the respective products. Any claims incurred before the implementation of the above measure will be processed based on the previous version of the designated hospital list in Mainland China. For access to the previous version of the list, please contact a Manulife financial advisor.
4 Excluding the Cancer Treatment Benefit.
5 The Credit Service for Hospitalization is exclusively available to customers of the “ManuMaster Healthcare Series/Benefit”, “ManuShine Healthcare Series/Benefit”, “Manulife Supreme VHIS Flexi Plan”, “Manulife Supreme Lite VHIS Supplementary Benefit”, “Manulife Supreme Medical Plan”, and “Manulife Supreme Lite Medical Supplementary Benefit”. The “ManuMaster Healthcare Series/Benefit” and “ManuShine Healthcare Series/Benefit” are available as basic plans or supplementary benefits.
6 The Credit Service for Hospitalization is a special administrative arrangement, not a product feature, nor part of any Voluntary Health Insurance Scheme (VHIS) certified plan, and is subject to terms and conditions. Whether this service can be arranged in Mainland China will depend on various factors and circumstances. For public hospitals in Mainland China, this service currently applies only to cases where there are no deductibles or out-of-pocket expenses. For private hospitals in Mainland China, the insured may be required to settle any deductible and/or net balance exceeding the pre-authorized amount upon discharge from the hospital. Once the hospital invoice is received and the claims assessment is completed, Manulife will notify the customer of any shortfall for payment, if any. Manulife reserves the right to terminate this service at any time without prior notice.
7 The Credit Service for Hospitalization is provided by a third party. Manulife makes no representation, warranty or undertaking as to the availability of and/or any service of the third party. Manulife shall not be liable to the policyowner or the life insured in any respect of any loss, damage, expense, suit, action or proceedings suffered or incurred by the policyowner or the life insured, whether directly or indirectly, arising from or in connection with the services provided (including, but not limited to, the Credit Service for Hospitalization) or advice given by the third party and/or its agents, or the availability of such services. In case of any dispute, the policyowner or the life insured should settle it with the third party directly.
8 Figures are as of August 11, 2025. Manulife reserves the right to review and update the list of hospitals offering the Credit Service for Hospitalization at its sole discretion from time to time without prior notice.
About Manulife Hong Kong
Manulife Hong Kong has been a trusted name for more than 125 years. Since our operations started in Asia in 1897, we have grown to become one of the top-tier providers of financial services, offering a diverse range of protection and wealth products and services to over 2.6 million customers in Hong Kong and Macau. We are committed to helping make decisions easier and lives better for our customers.
Manulife Hong Kong, through Manulife International Holdings Limited, owns Manulife (International) Limited, Manulife Investment Management (Hong Kong) Limited, and Manulife Provident Funds Trust Company Limited. These entities are all subsidiaries of Manulife Financial Corporation.
About Manulife
Manulife Financial Corporation is a leading international financial services provider, helping our customers make their decisions easier and lives better. With our global headquarters in Toronto, Canada, we operate as Manulife across Canada, Asia, and Europe, and primarily as John Hancock in the United States, providing financial advice and insurance for individuals, groups and businesses. Through Manulife Wealth & Asset Management, we offer global investment, financial advice, and retirement plan services to individuals, institutions, and retirement plan members worldwide. At the end of 2024, we had more than 37,000 employees, over 109,000 agents, and thousands of distribution partners, serving over 36 million customers. We trade as ‘MFC’ on the Toronto, New York, and the Philippine stock exchanges, and under ‘945’ in Hong Kong.
Not all offerings are available in all jurisdictions. For additional information, please visit manulife.com.
© 2002-2025 Manulife (International) Limited (Incorporated in Bermuda with limited liability)